[Pathophysiology and treatment of thrombosis. (2) Blood coagulation disorders and their modulation system].
作者信息
Sakuragawa N
出版信息
Nihon Naika Gakkai Zasshi. 1987 Jan;76(1):8-13.
PMID:3553383
Abstract
摘要
相似文献
1
[Pathophysiology and treatment of thrombosis. (2) Blood coagulation disorders and their modulation system].
Nihon Naika Gakkai Zasshi. 1987 Jan;76(1):8-13.
2
[The role of antithrombin III in disorders of blood coagulation].[抗凝血酶III在凝血紊乱中的作用]
Przegl Lek. 1988;45(6):516-20.
3
[Antithrombin III and its role in clinical pathology].[抗凝血酶III及其在临床病理学中的作用]
Ter Arkh. 1980;52(2):141-5.
4
Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis.
Arthritis Rheum. 1981 Jan;24(1):94-6. doi: 10.1002/art.1780240115.
5
Clinical relevance of antithrombin deficiencies.抗凝血酶缺乏症的临床相关性。
Semin Hematol. 1995 Oct;32(4 Suppl 2):2-6; discussion 7.
6
[Blood coagulation factors and glycosaminoglycans].[血液凝固因子与糖胺聚糖]
Rinsho Byori. 1987 Sep;Spec No 73:134-41.
7
Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow).一个患有1型抗凝血酶缺乏症（抗凝血酶克拉科夫型）的波兰家族中的动脉和静脉血栓形成及血栓前纤维蛋白凝块表型
Thromb Haemost. 2011 Aug;106(2):379-81. doi: 10.1160/TH11-02-0066. Epub 2011 Jun 9.
8
[The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].[血液凝固的生理性抑制剂。1. 抗凝血酶III（AT III）]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(3):337-49.
9
[Thrombosis].[血栓形成]
Gac Med Mex. 1989 Jul-Aug;125(7-8):181-201.
10
[Thrombosis: relation to blood coagulation mechanism].[血栓形成：与血液凝固机制的关系]
Nihon Naika Gakkai Zasshi. 1997 Jun 10;86(6):883-8.
Zotero 插件